Gendius, a forward-thinking digital health start-up, has reached a pivotal milestone by completing its Series A funding round.
The Cheshire-based firm aims to revolutionise diabetes management with its app, Intellin. This breakthrough platform is set to enhance the lives of many affected by this chronic condition.
Founded by Chris Genders and Rory Cameron, Gendius focuses on making diabetes management more effective through innovative technology. Their platform, Intellin, utilises an individual’s clinical history to predict areas prone to complications, thereby guiding users with clinically-validated tasks to mitigate progression.
Chris Spencer, a seasoned expert in healthcare technology and former CEO of EMIS Group, will join Gendius as non-executive chairman. His expertise will be instrumental in steering the company towards achieving its strategic goals.
Such financial backing underscores the app’s potential to make a significant impact in diabetes care.
This strategic alignment is essential for Gendius as they focus on enhancing healthcare outcomes through advanced digital applications.
Gendius stands at the forefront of this effort, offering solutions that are both innovative and economically significant.
As they continue to refine their platform, their focus on scalability and user accessibility remains paramount.
With a robust leadership team and strategic investment, the company is well-positioned to drive meaningful change in this critical area of healthcare.
The journey Gendius is undertaking reflects a commitment to improving lives through technology.
The combined expertise and financial backing set a solid foundation for future advancements in the healthcare technology space.